Sara Reardon. Show Affiliations »
Abstract
Mesh: See more » Biomedical Research/economicsFinancing, Organized/economicsFinancing, Organized/organization & administrationHumansLobbyingNational Institutes of Health (U.S.)/economicsNational Institutes of Health (U.S.)/organization & administrationPatient Advocacy/economicsRare Diseases/economicsUnited States
Year: 2014 PMID: 25373655 DOI: 10.1038/515019a
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962